INS and type 2 diabetes mellitus: Among 4,341 patients with type 2 diabetes taking insulin who are participating in the MOSAIc observational study, we found substantial variation across patients’ baseline demographic characteristics, medical history, drug treatment regimens, and self-reported knowledge of and distress about diabetes.